CompletedNot Applicable

Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ

Norway371 participantsStarted 2020-11-20

Plain-language summary

Purpose: to develop an international validated patient-reported outcome measure for COVID-19 patients according to international guidelines. In this phase III of the project, the preliminary questionnaire of 80 items will be tested. It has been developed based on literature review and interviews with health care professionals and patients (phase I-II). In Phase III A patients will fill in the questionnaire followed by interviews on relevance, importance and wording of the questionnaire In Phase III B patients will fill in the questionnaire and an debriefing questionnaire. We will do explorative psychometric analyses.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with verified SARS-CoV-2 infection (positive test according to local/national standards) * Patients with active or previous symptomatic COVID-19 disease * In-patients in hospitals and nursing homes or out-patients in hospitals or patients discharged from institutions to their home/covid-19 centres or patients staying at home/covid-19 centres during the course of the disease * Patients aged 18 years and older * Ability to read and comprehend the process and study documents as judged by the investigator * Written informed consent Exclusion Criteria: * Patients in intensive care units (can be recruited after they have been dismissed) * Inability to read and comprehend the process and study documents as judged by the investigator

What they're measuring

Validated COVID-19 specific questionnaire

Timeframe: 6 months

Trial details

NCT IDNCT04740372

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-15